Published: Aug-2022|  Format: PDF | QY Research |  Number of pages: 126 | Code: MBI-3387336

Molecular Diagnostics Cancer Market by Products (Pharmacogenomic Diagnosis, Liquid Biopsy, Other), by Applications (Respiratory Cancer, Cancer of Digestive System, Cancer of Urinary System, Cancer of Circulatory System) And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 - 2028

Select a Format




 Buy Now

The Global Molecular Diagnostics Cancer Market was valued at USD XXX in 2022 and it is projected to surpass around USD XX by 2030 with a registered CAGR of xxx during the forecast period 2022 to 2030.

Growth factor

Our new latest report titled, global Molecular Diagnostics Cancer Market comes up with comprehensive analysis of the industry including emerging trends and current development of the market. The report offers comprehensive insights of the industry with details of market share, size, revenue, growth opportunities, regional insights and major companies. The report provides all necessary and vital information related to the global market to help the buyer, the readers, investors get a complete understanding of the market and invest accordingly to the upcoming challenges and opportunities.

List of Key Players Operating in the Market:

The report provides in-depth research about each player operating in the global Molecular Diagnostics Cancer Market along with its worldwide financial position, previous and upcoming business expansion plans, new product launches. The upcoming activities of the key players related to various strategies such as acquisitions, partnerships, mergers and, joint ventures, research and development investments.

  • Roche
  • Danaher
  • Siemens
  • Abbott Laboratories
  • ICON Plc
  • AstraZeneca
  • MDxHealth
  • Invitae
  • PlexBio
  • Thermo Fisher Scientific
  • Guardant Health
  • Biocartis
  • Bio-Techne
  • Merck
  • Foundation Medicine
  • 10X Genomics
  • Biodesix
  • CytoTrack
  • GenomOncology
  • Luminex

Market research report presents an analysis of all the data collected through primary and secondary resources. Our well experienced team of analyst collects all the information from several leading entities press release, government publication sources such as gold standard, silver standard, white papers, articles and websites, corporate filings including financial statements, annual reports, investor presentations, etc.

Our Report offers detailed insights market valuation, volume, share, outlook, production capacity and price analysis for the forecast period 2022-2030. Furthermore, the study also includes market segmentation on the basis of product, application, end-users, supply chain, distribution channel and other segment. Additionally, the study also includes market segmentation based on upstream downstream demand analysis, feedstock, and consumption rate and market share. It employs both primary and secondary methods of data collection to obtain relevant and sustainable information of the market.

This exclusive report includes detailed information about the market related activities such as Partnerships, stake holder position, Sole Traders, which create, develop, and conduct activities for the study and analysis of markets as per the customization and specifications of the client.

Segment Analysis of the Market:

The objective of the report mainly provides an essential overview of the Molecular Diagnostics Cancer Market with detailed market segmentation by product, end-users, distribution channel, technology, content, type, application and region. The global market is expected to witness rapid growth during the forecast period. The report provides growth drivers, challenges, restraints of the region. It also offers the fastest growing segment with future scope, advancement emerging trends. The study examines the global scenario of the market by conducting an economy-wide assessment along with a comprehensive study involving product costs, drivers and restrictions, demands, profit analysis, production, distribution, and year-on-year growth rates.

By Type

  • Pharmacogenomic Diagnosis
  • Liquid Biopsy
  • Other

By Application

  • Respiratory Cancer
  • Cancer of Digestive System
  • Cancer of Urinary System
  • Cancer of Circulatory System
  • Motor System Cancer
  • Reproductive System Cancer
  • Other

Key Question Answered in this In-depth Market Report 2022-2028:

  • What was the market valued in the past year?
  • What will be the projected size, share and CAGR of the market?
  • What was the market status across the globe?
  • What are the profit margins in global Molecular Diagnostics Cancer Market?
  • What are the growth factors boosts the market for the forecast period?
  • Which segment is going to boom in the near future?
  • What are the upcoming trends of the market?
  • Who are the key companies or players of the market?
  • Which is the fastest growing region of the global Molecular Diagnostics Cancer Market?

Regional Insights:

The government initiative increasing the development activities of the Molecular Diagnostics Cancer Market. On the other hand the major reason behind the growth is the market key players are expanding their operation in this region.

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Exclusive Report Offers:

  1. To study and analyze the global Molecular Diagnostics Cancer Market consumption rate by key regions, type and application, historical data from past five years, and for upcoming years.
  2. The global research study look at the market to identify key influencing factors and entry barriers.
  3. To understand the structure of market by identifying and studying its various segments.
  4. To analyze with respect to individual prospects, growth factors, emerging trends, and their contribution to the whole market.
  5. Study focuses on the analysis of key players, to describe and analyze the sales volume, company size, share, value, market competition landscape, SWOT analysis and development plans in the near future.
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Molecular Diagnostics Cancer Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Pharmacogenomic Diagnosis
        1.2.3 Liquid Biopsy
        1.2.4 Other
    1.3 Market by Application
        1.3.1 Global Molecular Diagnostics Cancer Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Respiratory Cancer
        1.3.3 Cancer of Digestive System
        1.3.4 Cancer of Urinary System
        1.3.5 Cancer of Circulatory System
        1.3.6 Motor System Cancer
        1.3.7 Reproductive System Cancer
        1.3.8 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Molecular Diagnostics Cancer Market Perspective (2017-2028)
    2.2 Molecular Diagnostics Cancer Growth Trends by Region
        2.2.1 Molecular Diagnostics Cancer Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Molecular Diagnostics Cancer Historic Market Size by Region (2017-2022)
        2.2.3 Molecular Diagnostics Cancer Forecasted Market Size by Region (2023-2028)
    2.3 Molecular Diagnostics Cancer Market Dynamics
        2.3.1 Molecular Diagnostics Cancer Industry Trends
        2.3.2 Molecular Diagnostics Cancer Market Drivers
        2.3.3 Molecular Diagnostics Cancer Market Challenges
        2.3.4 Molecular Diagnostics Cancer Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Molecular Diagnostics Cancer Players by Revenue
        3.1.1 Global Top Molecular Diagnostics Cancer Players by Revenue (2017-2022)
        3.1.2 Global Molecular Diagnostics Cancer Revenue Market Share by Players (2017-2022)
    3.2 Global Molecular Diagnostics Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Molecular Diagnostics Cancer Revenue
    3.4 Global Molecular Diagnostics Cancer Market Concentration Ratio
        3.4.1 Global Molecular Diagnostics Cancer Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Cancer Revenue in 2021
    3.5 Molecular Diagnostics Cancer Key Players Head office and Area Served
    3.6 Key Players Molecular Diagnostics Cancer Product Solution and Service
    3.7 Date of Enter into Molecular Diagnostics Cancer Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics Cancer Breakdown Data by Type
    4.1 Global Molecular Diagnostics Cancer Historic Market Size by Type (2017-2022)
    4.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2023-2028)
5 Molecular Diagnostics Cancer Breakdown Data by Application
    5.1 Global Molecular Diagnostics Cancer Historic Market Size by Application (2017-2022)
    5.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Molecular Diagnostics Cancer Market Size (2017-2028)
    6.2 North America Molecular Diagnostics Cancer Market Size by Type
        6.2.1 North America Molecular Diagnostics Cancer Market Size by Type (2017-2022)
        6.2.2 North America Molecular Diagnostics Cancer Market Size by Type (2023-2028)
        6.2.3 North America Molecular Diagnostics Cancer Market Share by Type (2017-2028)
    6.3 North America Molecular Diagnostics Cancer Market Size by Application
        6.3.1 North America Molecular Diagnostics Cancer Market Size by Application (2017-2022)
        6.3.2 North America Molecular Diagnostics Cancer Market Size by Application (2023-2028)
        6.3.3 North America Molecular Diagnostics Cancer Market Share by Application (2017-2028)
    6.4 North America Molecular Diagnostics Cancer Market Size by Country
        6.4.1 North America Molecular Diagnostics Cancer Market Size by Country (2017-2022)
        6.4.2 North America Molecular Diagnostics Cancer Market Size by Country (2023-2028)
        6.4.3 U.S.
        6.4.4 Canada
7 Europe
    7.1 Europe Molecular Diagnostics Cancer Market Size (2017-2028)
    7.2 Europe Molecular Diagnostics Cancer Market Size by Type
        7.2.1 Europe Molecular Diagnostics Cancer Market Size by Type (2017-2022)
        7.2.2 Europe Molecular Diagnostics Cancer Market Size by Type (2023-2028)
        7.2.3 Europe Molecular Diagnostics Cancer Market Share by Type (2017-2028)
    7.3 Europe Molecular Diagnostics Cancer Market Size by Application
        7.3.1 Europe Molecular Diagnostics Cancer Market Size by Application (2017-2022)
        7.3.2 Europe Molecular Diagnostics Cancer Market Size by Application (2023-2028)
        7.3.3 Europe Molecular Diagnostics Cancer Market Share by Application (2017-2028)
    7.4 Europe Molecular Diagnostics Cancer Market Size by Country
        7.4.1 Europe Molecular Diagnostics Cancer Market Size by Country (2017-2022)
        7.4.2 Europe Molecular Diagnostics Cancer Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Molecular Diagnostics Cancer Market Size (2017-2028)
    8.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Type
        8.2.1 Asia-Pacific Molecular Diagnostics Cancer Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Molecular Diagnostics Cancer Market Share by Type (2017-2028)
    8.3 Asia-Pacific Molecular Diagnostics Cancer Market Size by Application
        8.3.1 Asia-Pacific Molecular Diagnostics Cancer Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Molecular Diagnostics Cancer Market Share by Application (2017-2028)
    8.4 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region
        8.4.1 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Molecular Diagnostics Cancer Market Size (2017-2028)
    9.2 Latin America Molecular Diagnostics Cancer Market Size by Type
        9.2.1 Latin America Molecular Diagnostics Cancer Market Size by Type (2017-2022)
        9.2.2 Latin America Molecular Diagnostics Cancer Market Size by Type (2023-2028)
        9.2.3 Latin America Molecular Diagnostics Cancer Market Share by Type (2017-2028)
    9.3 Latin America Molecular Diagnostics Cancer Market Size by Application
        9.3.1 Latin America Molecular Diagnostics Cancer Market Size by Application (2017-2022)
        9.3.2 Latin America Molecular Diagnostics Cancer Market Size by Application (2023-2028)
        9.3.3 Latin America Molecular Diagnostics Cancer Market Share by Application (2017-2028)
    9.4 Latin America Molecular Diagnostics Cancer Market Size by Country
        9.4.1 Latin America Molecular Diagnostics Cancer Market Size by Country (2017-2022)
        9.4.2 Latin America Molecular Diagnostics Cancer Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Molecular Diagnostics Cancer Market Size (2017-2028)
    10.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type
        10.2.1 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Molecular Diagnostics Cancer Market Share by Type (2017-2028)
    10.3 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application
        10.3.1 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Molecular Diagnostics Cancer Market Share by Application (2017-2028)
    10.4 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country
        10.4.1 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Roche
        11.1.1 Roche Company Details
        11.1.2 Roche Business Overview
        11.1.3 Roche Molecular Diagnostics Cancer Introduction
        11.1.4 Roche Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.1.5 Roche Recent Developments
    11.2 Danaher
        11.2.1 Danaher Company Details
        11.2.2 Danaher Business Overview
        11.2.3 Danaher Molecular Diagnostics Cancer Introduction
        11.2.4 Danaher Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.2.5 Danaher Recent Developments
    11.3 Siemens
        11.3.1 Siemens Company Details
        11.3.2 Siemens Business Overview
        11.3.3 Siemens Molecular Diagnostics Cancer Introduction
        11.3.4 Siemens Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.3.5 Siemens Recent Developments
    11.4 Abbott Laboratories
        11.4.1 Abbott Laboratories Company Details
        11.4.2 Abbott Laboratories Business Overview
        11.4.3 Abbott Laboratories Molecular Diagnostics Cancer Introduction
        11.4.4 Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.4.5 Abbott Laboratories Recent Developments
    11.5 ICON Plc
        11.5.1 ICON Plc Company Details
        11.5.2 ICON Plc Business Overview
        11.5.3 ICON Plc Molecular Diagnostics Cancer Introduction
        11.5.4 ICON Plc Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.5.5 ICON Plc Recent Developments
    11.6 AstraZeneca
        11.6.1 AstraZeneca Company Details
        11.6.2 AstraZeneca Business Overview
        11.6.3 AstraZeneca Molecular Diagnostics Cancer Introduction
        11.6.4 AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.6.5 AstraZeneca Recent Developments
    11.7 MDxHealth
        11.7.1 MDxHealth Company Details
        11.7.2 MDxHealth Business Overview
        11.7.3 MDxHealth Molecular Diagnostics Cancer Introduction
        11.7.4 MDxHealth Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.7.5 MDxHealth Recent Developments
    11.8 Invitae
        11.8.1 Invitae Company Details
        11.8.2 Invitae Business Overview
        11.8.3 Invitae Molecular Diagnostics Cancer Introduction
        11.8.4 Invitae Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.8.5 Invitae Recent Developments
    11.9 PlexBio
        11.9.1 PlexBio Company Details
        11.9.2 PlexBio Business Overview
        11.9.3 PlexBio Molecular Diagnostics Cancer Introduction
        11.9.4 PlexBio Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.9.5 PlexBio Recent Developments
    11.10 Thermo Fisher Scientific
        11.10.1 Thermo Fisher Scientific Company Details
        11.10.2 Thermo Fisher Scientific Business Overview
        11.10.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Introduction
        11.10.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.10.5 Thermo Fisher Scientific Recent Developments
    11.11 Guardant Health
        11.11.1 Guardant Health Company Details
        11.11.2 Guardant Health Business Overview
        11.11.3 Guardant Health Molecular Diagnostics Cancer Introduction
        11.11.4 Guardant Health Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.11.5 Guardant Health Recent Developments
    11.12 Biocartis
        11.12.1 Biocartis Company Details
        11.12.2 Biocartis Business Overview
        11.12.3 Biocartis Molecular Diagnostics Cancer Introduction
        11.12.4 Biocartis Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.12.5 Biocartis Recent Developments
    11.13 Bio-Techne
        11.13.1 Bio-Techne Company Details
        11.13.2 Bio-Techne Business Overview
        11.13.3 Bio-Techne Molecular Diagnostics Cancer Introduction
        11.13.4 Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.13.5 Bio-Techne Recent Developments
    11.14 Merck
        11.14.1 Merck Company Details
        11.14.2 Merck Business Overview
        11.14.3 Merck Molecular Diagnostics Cancer Introduction
        11.14.4 Merck Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.14.5 Merck Recent Developments
    11.15 Foundation Medicine
        11.15.1 Foundation Medicine Company Details
        11.15.2 Foundation Medicine Business Overview
        11.15.3 Foundation Medicine Molecular Diagnostics Cancer Introduction
        11.15.4 Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.15.5 Foundation Medicine Recent Developments
    11.16 10X Genomics
        11.16.1 10X Genomics Company Details
        11.16.2 10X Genomics Business Overview
        11.16.3 10X Genomics Molecular Diagnostics Cancer Introduction
        11.16.4 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.16.5 10X Genomics Recent Developments
    11.17 Biodesix
        11.17.1 Biodesix Company Details
        11.17.2 Biodesix Business Overview
        11.17.3 Biodesix Molecular Diagnostics Cancer Introduction
        11.17.4 Biodesix Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.17.5 Biodesix Recent Developments
    11.18 CytoTrack
        11.18.1 CytoTrack Company Details
        11.18.2 CytoTrack Business Overview
        11.18.3 CytoTrack Molecular Diagnostics Cancer Introduction
        11.18.4 CytoTrack Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.18.5 CytoTrack Recent Developments
    11.19 GenomOncology
        11.19.1 GenomOncology Company Details
        11.19.2 GenomOncology Business Overview
        11.19.3 GenomOncology Molecular Diagnostics Cancer Introduction
        11.19.4 GenomOncology Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.19.5 GenomOncology Recent Developments
    11.20 Luminex
        11.20.1 Luminex Company Details
        11.20.2 Luminex Business Overview
        11.20.3 Luminex Molecular Diagnostics Cancer Introduction
        11.20.4 Luminex Revenue in Molecular Diagnostics Cancer Business (2017-2022)
        11.20.5 Luminex Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables Table 1. Global Molecular Diagnostics Cancer Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Pharmacogenomic Diagnosis Table 3. Key Players of Liquid Biopsy Table 4. Key Players of Other Table 5. Global Molecular Diagnostics Cancer Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global Molecular Diagnostics Cancer Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Molecular Diagnostics Cancer Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Molecular Diagnostics Cancer Market Share by Region (2017-2022) Table 9. Global Molecular Diagnostics Cancer Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Molecular Diagnostics Cancer Market Share by Region (2023-2028) Table 11. Molecular Diagnostics Cancer Market Trends Table 12. Molecular Diagnostics Cancer Market Drivers Table 13. Molecular Diagnostics Cancer Market Challenges Table 14. Molecular Diagnostics Cancer Market Restraints Table 15. Global Molecular Diagnostics Cancer Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Molecular Diagnostics Cancer Revenue Share by Players (2017-2022) Table 17. Global Top Molecular Diagnostics Cancer by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Cancer as of 2021) Table 18. Ranking of Global Top Molecular Diagnostics Cancer Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Molecular Diagnostics Cancer Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Molecular Diagnostics Cancer Product Solution and Service Table 22. Date of Enter into Molecular Diagnostics Cancer Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Molecular Diagnostics Cancer Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2017-2022) Table 26. Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2023-2028) Table 28. Global Molecular Diagnostics Cancer Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Molecular Diagnostics Cancer Revenue Share by Application (2017-2022) Table 30. Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Molecular Diagnostics Cancer Revenue Share by Application (2023-2028) Table 32. North America Molecular Diagnostics Cancer Market Size by Type (2017-2022) & (US$ Million) Table 33. North America Molecular Diagnostics Cancer Market Size by Type (2023-2028) & (US$ Million) Table 34. North America Molecular Diagnostics Cancer Market Size by Application (2017-2022) & (US$ Million) Table 35. North America Molecular Diagnostics Cancer Market Size by Application (2023-2028) & (US$ Million) Table 36. North America Molecular Diagnostics Cancer Market Size by Country (2017-2022) & (US$ Million) Table 37. North America Molecular Diagnostics Cancer Market Size by Country (2023-2028) & (US$ Million) Table 38. Europe Molecular Diagnostics Cancer Market Size by Type (2017-2022) & (US$ Million) Table 39. Europe Molecular Diagnostics Cancer Market Size by Type (2023-2028) & (US$ Million) Table 40. Europe Molecular Diagnostics Cancer Market Size by Application (2017-2022) & (US$ Million) Table 41. Europe Molecular Diagnostics Cancer Market Size by Application (2023-2028) & (US$ Million) Table 42. Europe Molecular Diagnostics Cancer Market Size by Country (2017-2022) & (US$ Million) Table 43. Europe Molecular Diagnostics Cancer Market Size by Country (2023-2028) & (US$ Million) Table 44. Asia Pacific Molecular Diagnostics Cancer Market Size by Type (2017-2022) & (US$ Million) Table 45. Asia Pacific Molecular Diagnostics Cancer Market Size by Type (2023-2028) & (US$ Million) Table 46. Asia Pacific Molecular Diagnostics Cancer Market Size by Application (2017-2022) & (US$ Million) Table 47. Asia Pacific Molecular Diagnostics Cancer Market Size by Application (2023-2028) & (US$ Million) Table 48. Asia Pacific Molecular Diagnostics Cancer Market Size by Region (2017-2022) & (US$ Million) Table 49. Asia Pacific Molecular Diagnostics Cancer Market Size by Region (2023-2028) & (US$ Million) Table 50. Latin America Molecular Diagnostics Cancer Market Size by Type (2017-2022) & (US$ Million) Table 51. Latin America Molecular Diagnostics Cancer Market Size by Type (2023-2028) & (US$ Million) Table 52. Latin America Molecular Diagnostics Cancer Market Size by Application (2017-2022) & (US$ Million) Table 53. Latin America Molecular Diagnostics Cancer Market Size by Application (2023-2028) & (US$ Million) Table 54. Latin America Molecular Diagnostics Cancer Market Size by Country (2017-2022) & (US$ Million) Table 55. Latin America Molecular Diagnostics Cancer Market Size by Country (2023-2028) & (US$ Million) Table 56. Middle East and Africa Molecular Diagnostics Cancer Market Size by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa Molecular Diagnostics Cancer Market Size by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa Molecular Diagnostics Cancer Market Size by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa Molecular Diagnostics Cancer Market Size by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa Molecular Diagnostics Cancer Market Size by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa Molecular Diagnostics Cancer Market Size by Country (2023-2028) & (US$ Million) Table 62. Roche Company Details Table 63. Roche Business Overview Table 64. Roche Molecular Diagnostics Cancer Product Table 65. Roche Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 66. Roche Recent Developments Table 67. Danaher Company Details Table 68. Danaher Business Overview Table 69. Danaher Molecular Diagnostics Cancer Product Table 70. Danaher Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 71. Danaher Recent Developments Table 72. Siemens Company Details Table 73. Siemens Business Overview Table 74. Siemens Molecular Diagnostics Cancer Product Table 75. Siemens Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 76. Siemens Recent Developments Table 77. Abbott Laboratories Company Details Table 78. Abbott Laboratories Business Overview Table 79. Abbott Laboratories Molecular Diagnostics Cancer Product Table 80. Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 81. Abbott Laboratories Recent Developments Table 82. ICON Plc Company Details Table 83. ICON Plc Business Overview Table 84. ICON Plc Molecular Diagnostics Cancer Product Table 85. ICON Plc Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 86. ICON Plc Recent Developments Table 87. AstraZeneca Company Details Table 88. AstraZeneca Business Overview Table 89. AstraZeneca Molecular Diagnostics Cancer Product Table 90. AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 91. AstraZeneca Recent Developments Table 92. MDxHealth Company Details Table 93. MDxHealth Business Overview Table 94. MDxHealth Molecular Diagnostics Cancer Product Table 95. MDxHealth Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 96. MDxHealth Recent Developments Table 97. Invitae Company Details Table 98. Invitae Business Overview Table 99. Invitae Molecular Diagnostics Cancer Product Table 100. Invitae Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 101. Invitae Recent Developments Table 102. PlexBio Company Details Table 103. PlexBio Business Overview Table 104. PlexBio Molecular Diagnostics Cancer Product Table 105. PlexBio Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 106. PlexBio Recent Developments Table 107. Thermo Fisher Scientific Company Details Table 108. Thermo Fisher Scientific Business Overview Table 109. Thermo Fisher Scientific Molecular Diagnostics Cancer Product Table 110. Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 111. Thermo Fisher Scientific Recent Developments Table 112. Guardant Health Company Details Table 113. Guardant Health Business Overview Table 114. Guardant Health Molecular Diagnostics Cancer Product Table 115. Guardant Health Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 116. Guardant Health Recent Developments Table 117. Biocartis Company Details Table 118. Biocartis Business Overview Table 119. Biocartis Molecular Diagnostics Cancer Product Table 120. Biocartis Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 121. Biocartis Recent Developments Table 122. Bio-Techne Company Details Table 123. Bio-Techne Business Overview Table 124. Bio-Techne Molecular Diagnostics Cancer Product Table 125. Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 126. Bio-Techne Recent Developments Table 127. Merck Company Details Table 128. Merck Business Overview Table 129. Merck Molecular Diagnostics Cancer Product Table 130. Merck Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 131. Merck Recent Developments Table 132. Foundation Medicine Company Details Table 133. Foundation Medicine Business Overview Table 134. Foundation Medicine Molecular Diagnostics Cancer Product Table 135. Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 136. Foundation Medicine Recent Developments Table 137. 10X Genomics Company Details Table 138. 10X Genomics Business Overview Table 139. 10X Genomics Molecular Diagnostics Cancer Product Table 140. 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 141. 10X Genomics Recent Developments Table 142. Biodesix Company Details Table 143. Biodesix Business Overview Table 144. Biodesix Molecular Diagnostics Cancer Product Table 145. Biodesix Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 146. Biodesix Recent Developments Table 147. CytoTrack Company Details Table 148. CytoTrack Business Overview Table 149. CytoTrack Molecular Diagnostics Cancer Product Table 150. CytoTrack Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 151. CytoTrack Recent Developments Table 152. GenomOncology Company Details Table 153. GenomOncology Business Overview Table 154. GenomOncology Molecular Diagnostics Cancer Product Table 155. GenomOncology Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 156. GenomOncology Recent Developments Table 157. Luminex Company Details Table 158. Luminex Business Overview Table 159. Luminex Molecular Diagnostics Cancer Product Table 160. Luminex Revenue in Molecular Diagnostics Cancer Business (2017-2022) & (US$ Million) Table 161. Luminex Recent Developments Table 162. Research Programs/Design for This Report Table 163. Key Data Information from Secondary Sources Table 164. Key Data Information from Primary Sources List of Figures Figure 1. Global Molecular Diagnostics Cancer Market Share by Type: 2021 VS 2028 Figure 2. Pharmacogenomic Diagnosis Features Figure 3. Liquid Biopsy Features Figure 4. Other Features Figure 5. Global Molecular Diagnostics Cancer Market Share by Application: 2021 VS 2028 Figure 6. Respiratory Cancer Case Studies Figure 7. Cancer of Digestive System Case Studies Figure 8. Cancer of Urinary System Case Studies Figure 9. Cancer of Circulatory System Case Studies Figure 10. Motor System Cancer Case Studies Figure 11. Reproductive System Cancer Case Studies Figure 12. Other Case Studies Figure 13. Molecular Diagnostics Cancer Report Years Considered Figure 14. Global Molecular Diagnostics Cancer Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 15. Global Molecular Diagnostics Cancer Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 16. Global Molecular Diagnostics Cancer Market Share by Region: 2021 VS 2028 Figure 17. Global Molecular Diagnostics Cancer Market Share by Players in 2021 Figure 18. Global Top Molecular Diagnostics Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics Cancer as of 2021) Figure 19. The Top 10 and 5 Players Market Share by Molecular Diagnostics Cancer Revenue in 2021 Figure 20. North America Molecular Diagnostics Cancer Market Size YoY (2017-2028) & (US$ Million) Figure 21. North America Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2028) Figure 22. North America Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2028) Figure 23. North America Molecular Diagnostics Cancer Market Size Share by Country (2017-2028) Figure 24. United States Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Canada Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Europe Molecular Diagnostics Cancer Market Size YoY (2017-2028) & (US$ Million) Figure 27. Europe Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2028) Figure 28. Europe Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2028) Figure 29. Europe Molecular Diagnostics Cancer Market Size Share by Country (2017-2028) Figure 30. Germany Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. France Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. U.K. Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Italy Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Russia Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Nordic Countries Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Asia-Pacific Molecular Diagnostics Cancer Market Size YoY (2017-2028) & (US$ Million) Figure 37. Asia Pacific Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2028) Figure 38. Asia Pacific Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2028) Figure 39. Asia Pacific Molecular Diagnostics Cancer Market Size Share by Region (2017-2028) Figure 40. China Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Japan Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. South Korea Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Southeast Asia Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. India Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Australia Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 46. Latin America Molecular Diagnostics Cancer Market Size YoY (2017-2028) & (US$ Million) Figure 47. Latin America Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2028) Figure 48. Latin America Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2028) Figure 49. Latin America Molecular Diagnostics Cancer Market Size Share by Country (2017-2028) Figure 50. Mexico Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 51. Brazil Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 52. Middle East & Africa Molecular Diagnostics Cancer Market Size YoY (2017-2028) & (US$ Million) Figure 53. Middle East and Africa Molecular Diagnostics Cancer Market Size Market Share by Type (2017-2028) Figure 54. Middle East and Africa Molecular Diagnostics Cancer Market Size Market Share by Application (2017-2028) Figure 55. Middle East and Africa Molecular Diagnostics Cancer Market Size Share by Country (2017-2028) Figure 56. Turkey Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 57. Saudi Arabia Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 58. UAE Molecular Diagnostics Cancer Market Size YoY Growth (2017-2028) & (US$ Million) Figure 59. Roche Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 60. Danaher Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 61. Siemens Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 62. Abbott Laboratories Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 63. ICON Plc Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 64. AstraZeneca Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 65. MDxHealth Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 66. Invitae Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 67. PlexBio Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 68. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 69. Guardant Health Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 70. Biocartis Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 71. Bio-Techne Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 72. Merck Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 73. Foundation Medicine Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 74. 10X Genomics Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 75. Biodesix Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 76. CytoTrack Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 77. GenomOncology Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 78. Luminex Revenue Growth Rate in Molecular Diagnostics Cancer Business (2017-2022) Figure 79. Bottom-up and Top-down Approaches for This Report Figure 80. Data Triangulation Figure 81. Key Executives Interviewed



Inquiry before buying

Request Sample

Request for Discount

Latest News

Global Cancer Immunotherapy Market to Grow at a (CAGR) of 13.9% during the Forecast Period 2022-2030

18-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global  Cancer Immunotherapy Market is projected to reach USD 275.5 billion by 2030. Moreover, increasing day-by-day incidence of cancer, increasing awareness about early diagnosis, the effectiveness of thera ...

Global In-Vehicle Infotainment Market to Grow at a (CAGR) of 9.8% during the Forecast Period 2022-2030

17-Nov-2022 | Automobile

As specified in our exclusive report, the global  In-Vehicle Infotainment Market is projected to reach USD 42.25 billion by 2030. In-vehicle infotainment systems provide entertainment and information services to the driver and passengers throughou ...

Global Blockchain in Healthcare Market to Grow at a (CAGR) of 59% during the Forecast Period 2022-2030

16-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global Blockchain in Healthcare Market is projected to reach USD 119 billion by 2030. The growing need for curbing these issues along with the increasing incidence of information leaks and data breaches has be ...

Global In Vitro Fertilization Market to Grow at a (CAGR) of 5.7% during the Forecast Period 2022-2030

14-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the Global In-Vitro Fertilization Market is projected to reach USD 32 billion by 2030. In-vitro fertilization involves some risks such as genetic disease transfer during the pr ...

Global Microfluidics Market to Grow at a (CAGR) of 15.8% during the Forecast Period 2022-2030

11-Nov-2022 | Pharmaceuticals & Healthcare

As specified in our exclusive report, the global  Microfluidics Market is projected to reach USD 61 billion by 2030. The growth in demand for point-of-care (POC) devices is expected to majorly drive the market size in the coming years. Simultaneously demand ...

More News...